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Background: Lens epithelium–derived growth factor (LEDGF/p75) is a cellular co-factor of HIV-1 integrase (IN) that
tethers the viral pre-integration complex to the host cell chromatin and determines the genome wide integration
site distribution pattern of HIV-1. Recently, we demonstrated that HIV-1 replication was reduced in LEDGF/p75
knockout (KO) cells. LEDGF/p75 KO significantly altered the integration site preference of HIV-1, but the pattern
remained distinct from a computationally generated matched random control set (MRC), suggesting the presence
of an alternative tethering factor. We previously identified Hepatoma-derived growth factor related protein 2
(HRP-2) as a factor mediating LEDGF/p75-independent HIV-1 replication. However, the role of HRP-2 in HIV-1
integration site selection was not addressed.
Findings: We studied the HIV-1 integration site distribution in the presence and absence of LEDGF/p75 and/or
HRP-2, and in LEDGF/p75-depleted cells that overexpress HRP-2. We show that HRP-2 functions as a co-factor of
HIV-1 IN in LEDGF/p75-depleted cells. Endogenous HRP-2 only weakly supported HIV-1 replication in LEDGF/p75
depleted cells. However, HRP-2 overexpression rescued HIV-1 replication and restored integration in RefSeq genes
to wild-type levels. Additional HRP-2 KD in LEDGF/p75-depleted cells reduces integration frequency in transcription
units and shifts the integration distribution towards random.
Conclusions: We demonstrate that HRP-2 overexpression can compensate for the absence of LEDGF/p75 and
indicate that the residual bias in integration targeting observed in the absence of LEDGF/p75 can be ascribed to
HRP-2. Knockdown of HRP-2 upon LEDGF/p75 depletion results in a more random HIV-1 integration pattern. These
data therefore reinforce the understanding that LEDGF/p75 is the dominant HIV-1 IN co-factor.
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HIV-1 integration target site selection is not a random
event, but preferentially occurs in the body of active
transcription units [1], due to the interaction with the
cellular co-factor LEDGF/p75 [2,3]. Knockdown (KD) or
KO of LEDGF/p75 shifts HIV-1 integration targeting
away from transcription units [2-7]. LEDGF/p75 func-
tions as a molecular tether, interacting with the viral
integrase (IN) via its C-terminal integrase binding do-
main (IBD) [8,9], and with the host-cell chromatin via its
N-terminus. The latter contains chromatin-binding
motifs such as the PWWP-domain, AT-hook-like motifs,
and a set of charged regions (Figure 1) [6,10]. Several* Correspondence: rik.gijsbers@med.kuleuven.be
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reproduction in any medium, provided the orlines of evidence support this tethering and targeting
model for LEDGF/p75 in HIV-1 replication. The chro-
matin binding sites of LEDGF/p75 correlate with the
HIV-1 integration distribution pattern [11], and LEDGF/
p75-hybrids in which the N-terminus is replaced by an
alternative chromatin interaction domain, such as the
heterochromatin binding element CBX1, have been
shown to retarget HIV-1 integration out of transcription
units and towards heterochromatic regions [5,12].
We reported that LEDGF/p75 KO shifts HIV-1 inte-
gration away from transcription units [7], consistent
with previous LEDGF/p75 KD experiments [2,3]. How-
ever, even in the absence of LEDGF/p75, HIV-1 signifi-
cantly favored integration in transcription units when
compared to random [7]. This may be explained by an
intrinsic feature of the IN protein or the pre-integration
complex, or by the presence of one or more additionalal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and






















Figure 1 Structure of LEDGF/p75 and HRP-2. Cartoon representation of LEDGF/p75 and HRP-2: PWWP-domain (PWWP), charged region 1–3
(CR1-3), nuclear localization signal (NLS), AT hook-like sequence (AT), homology region III (HR III) [9] and integrase binding domain (IBD).
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Recently, we reported that HRP-2, the only known cellu-
lar protein besides LEDGF/p75 that combines a PWWP-
domain and an IBD-like domain [9,13] (Figure 1), plays
a role in LEDGF/p75-independent HIV-1 replication
in both human LEDGF/p75 KO and KD cell lines [7].
In this study we examined the contribution of HRP-2 in
directing integration site selection of HIV-1.
We and others have demonstrated that back-
complementation (BC) of LEDGF/p75 in LEDGF/p75-
depleted cells rescued HIV-1 replication and restored
the integration site distribution to wild-type (wild-type)
patterns [5,14]. Here, we first assessed the potential of
HRP-2 to complement LEDGF/p75-depleted cells. Over-
expression of HRP-2 (9-fold compared to endogenous
wild-type levels, Figure 2A) in LEDGF/p75-depleted cells
could substitute in part for LEDGF/p75. Infection with
single-round HIV-fLuc virus was restored to 62 ± 8%
compared to LEDGF/p75 BC cells (Figure 2B, compare
LEDGF/p75 BC and LEDGF/p75 KD+HRP-2). Replica-
tion of HIV-1NL4.3 virus was rescued to near wild-type
levels upon HRP-2 overexpression as seen with LEDGF/
p75 BC (Figure 2C). Both LEDGF/p75 and HRP-2
mediated rescue correlated with an increase in inte-
grated proviral copies (Figure 2D). Next, in line with
previous observations [15], the nuclear distribution pat-
tern of LEDGF/p75 during interphase was speckled,
while that of HRP-2 was homogenous (Additional file 1,
compare row 2 and 3). Unlike LEDGF/p75, HRP-2 did
not bind mitotic chromosomes (Additional file 1, com-
pare row 5 and 6), although this might not be relevant
for HIV-1 replication since LEDGF/p75 depletion in
non-dividing macrophages also affects HIV-1 replication
[16]. Still, HRP-2 overexpression relocated IN to thenucleus in LEDGF/p75 KD cells (Additional file 1, row
3), suggesting a direct interaction.
Previously, we demonstrated that HRP-2 KD in
LEDGF/p75-depleted cells additionally hampered HIV-1
replication (see reference [7] and data not shown). Here,
we evaluated the effect of additional HRP-2 KD in
LEDGF/p75-depleted cells on HIV-1 integration site dis-
tribution. We generated stable HRP-2 KD and LEDGF/
p75 KD cells (86% and >90% KD on mRNA level for
HRP-2 and LEDGF/p75, respectively), double KD cells
(>90% LEDGF/p75 KD and 84% HRP-2 KD on mRNA
level) and complemented LEDGF/p75 KD cells with
HRP-2 (Figure 2A and data not shown). The respective
cell lines were challenged with HIV-fLuc integration
sites were amplified and their distribution pattern was
characterized.
First, we generated a genomic heat map describing the
integration site distribution for a subset of genomic fea-
tures (Additional file 2). The color of each tile represents
the deviation from random (MRC=0.5) for the exam-
ined feature, ranging from red (favored compared to
MRC) over white to blue (disfavored compared to
MRC). While tile colors did not differ when HRP-2 was
depleted in wild-type cells (compare wild-type and
HRP-2 KD), a shift in tile color towards random could
be appreciated upon LEDGF/p75 KD (compare wild-
type and LEDGF/p75 KD), which was even more pro-
nounced upon the additional suppression of HRP-2 ex-
pression (compare LEDGF/p75 KD and LEDGF/p75 KD
HRP-2 KD). More detailed analysis showed that integra-
tion in RefSeq genes was favored in wild-type cells
(77.5% in genes, p < 0.001 compared to MRC) and
decreased significantly upon LEDGF/p75 KD (67.7% in































































































































































Figure 2 HRP-2 overexpression rescues HIV-1 replication. WT and stable LEDGF/p75 KD cell lines (LEDGF/p75 KD) were complemented with
LEDGF/p75 (LEDGF/p75 BC) or HRP-2 (LEDGF/p75 KD+HRP-2). (A) HRP-2 mRNA expression levels shown as fold overexpression compared to WT.
(B) Relative luciferase activity (RLU/μg protein) following HIV-fLuc transduction. Data were compiled from at least six independent experiments
and expressed as percentages relative to LEDGF/p75 BC (mean± SD). (C) Multiple round HIV-1 replication after challenging the indicated cell lines
with the laboratory strain HIV-1NL4.3. Replication was monitored by measuring the p24 content in the supernatant until day 10 at which point
cells were confluent or showed massive cell death due to CPE. P24 levels decreased after day 8 in the WT condition due to CPE. Experiments
were performed at least three times, a representative experiment is shown. (D) At day 10 of the experiment shown in (C), cells were split and
maintained under antiretroviral therapy (AZT, 50xIC50) for 10 days to dilute all non-integrated viral DNA forms, before determining the number of
integrated copies using qPCR.
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overexpression in LEDGF/p75 KD cells rescued pro-
viral integration in transcription units (77.5%, no dif-
ference compared to wild-type; Table 1, Figure 3 and
Additional file 2). KD of HRP-2 in wild-type cells did
not affect integration site distribution (80.2% in genes,
p = 0.3 for the comparison of wild-type and HRP-2 KD),
confirming the dominant role of LEDGF/p75 over HRP-2.
However, KD of HRP-2 in LEDGF/p75-depleted cells
resulted in an additional decrease of integration in RefSeq
genes, shifting integration out of transcription units and
towards random (67.7% in LEDGF/p75 KD versus 53.7%in LEDGF/p75 KD HRP-2 KD, p < 0.001) (Table 1,
Figure 3). Together these data provide evidence for a role
of HRP-2 in targeting HIV-1 integration in LEDGF/
p75-depleted cells. Using a panel of histone modifica-
tions we also evaluated the frequency of integration
near transcriptionally repressed regions (either silent
regions, e.g. H3K27me3, or heterochromatin, e.g. H3K
9me3, H3K79me3, H4K20me3), as well as near marks
associated with activation (e.g. H2BK5me1, H3K9me1,
and H4K20me1). Since only a limited number of
marks have been mapped in HeLa cells [17], we also
included marks that were defined in CD4+ T-cells
Table 1 Integration frequency of HIV in RefSeq genes
Cell line # sites % in RefSeq genes
HIV-fLuc WT 1468 77.5 ***|ns|***
sites HRP-2 KD 359 80.2 ***|ns|***
LEDGF/p75 KD 477 67.7 ***|***|ns
LEDGF/p75 KD HRP-2 KD 676 53.7 ***|***|***
LEDGF/p75 KD+HRP-2 445 77.5 ***|ns|***
MRC sites WT 4404 39.7
(HIV-fLuc) HRP-2 KD 1077 37.9
LEDGF/p75 KD 1431 40.3
LEDGF/p75 KD HRP-2 KD 2028 39.3
LEDGF/p75 KD+HRP-2 1335 40.2
Abbreviations: MRC matched random control, ns non-significant (p≥ 0.05).
Asterisks represent p-values (*p < 0.05, **p < 0.01, ***p < 0.001) given after
comparison with MRC|WT|LEDGF/p75 KD respectively. Significance was
determined using a two-tailed Chi-square test. P-values were not corrected for
































































Figure 3 HRP-2 affects HIV-1 integration in genes. Integration
events of HIV-1 (HIV-fLuc) in genes according to the RefSeq
annotation were normalized to MRC and presented per cell line. The
line at y = 1.0 represents random integration (equal to MRC).
Asterisks represent statistical significance of differences between two
data sets, indicated by the line above the two sets, with * p < 0.05,
** p < 0.01, *** p < 0.001, using a two-tailed Chi-Square test.
Statistical methods are described in detail by Berry et al. [20].
Analysis was carried out using The R Project for Statistical
Computing software. P-values were not corrected for multiple
comparisons; alpha level is 0.007 after Bonferroni correction (0.05/7).
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generally disfavored near marks associated with tran-
scriptionally silent regions and heterochromatin.
LEDGF/p75 depletion shifts this phenotype more to
MRC. In line with our previous data, additional HRP-2
KD in LEDGF/p75-depleted cells shifted integration distri-
bution more towards MRC, indicating that the integration
is more random upon double KD (Figure 4, compare
LEDGF/p75 KD and LEDGF/p75 KD HRP-2 KD). Like-
wise, integration near histone marks associated with active
transcription is reduced upon LEDGF/p75 KD and even
more upon additional HRP-2 KD. HRP-2 overexpression
restored the integration pattern near histone marks to
levels observed in wild-type cells. The possible effects of
such altered integration site distribution on proviral gene
expression remain to be investigated. Since LEDGINs
[19], allosteric IN inhibitors targeting the LEDGF/p75
binding site in IN, interfere with the interaction of either
LEDGF/p75 or HRP-2 [7], LEDGINs might affect HIV-1
integration site distribution. Comparable data were
obtained when transducing the same cell lines with an
HIV-derived lentiviral vector (Additional file 3; Table S1).
Taken together, our work underscores the dominant
role of LEDGF/p75 over HRP-2 in HIV-1 replication,
which can be explained by the lower affinity of HRP-2
for HIV-1 IN compared to LEDGF/p75 [7,9,15]. Since
HRP-2 overexpression in LEDGF/p75-depleted cells res-
cues HIV-1 replication, the relative expression levels of
LEDGF/p75 and HRP-2 in relevant primary host cells
are of importance. Different groups have reported on ex-
pression levels of LEDGF/p75 in primary activated and
resting T-cells [21] or in different patient populations
[22,23], yet the levels in other subsets of HIV target-cells
as well as the HRP-2 expression levels remain to bedetermined. Currently, there is no evidence that HRP-2
plays a role in HIV-1 replication in cells expressing WT
levels of LEDGF/p75. Both LEDGF/p75 and HRP-2 carry
a PWWP domain, recently identified as a chromatin
reader recognizing epigenetic marks, such as methylated
histone side-chains [6,24,25]. Previously, we demon-
strated that swapping the PWWP-domain of LEDGF/
p75 with that of HRP-2 could rescue lentiviral repli-
cation and integration site selection in genes [6]. Here,
integration distribution in LEDGF/p75 KD cells over-
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Figure 4 LEDGF/p75 and HRP-2 depletion shifts integration towards random. A pooled score was determined for HIV-1 integration near
epigenetic marks associated with transcriptional repression or activation for each cell line and plotted in a bar diagram. The X-axis represents
deviation from random with positive values indicating favored integration compared to MRC, negative values disfavored integration compared to
MRC. The pooled score is the average of the different ROC values - 0.5 (to indicate the deviation from random) obtained with individual markers
(not shown) in a 10 kb window. For HeLaP4, H3K9me2, H3K9me3, H3K27me3, and H4K20me3 were pooled as associated with ‘repression’;
H2BK5me1, H3K4me1, H3K36me3, H4K20me1 were pooled as associated with ‘activation’. For CD4+ T-cells, H3K9me2, H3K9me3, H3K27me2,
H3K27me3, H3K79me3 and H4K20me3 were pooled as associated with ‘repression’; H2BK5me1, H3K4me1, H3K4me2, H3K9me1, H3K27me1,
H3K36me3, H4K20me1 were pooled as associated with ‘activation’.
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subtle differences between LEDGF/p75 and HRP-2 for
the interaction with the local chromatin. Although
LEDGF/p75 and HRP-2 double KD shifted integration
significantly out of transcription units, integration
remained distinct from random in the double KD cells
(Table 1). Multiple (mutually non-exclusive) reasons can
be put forward to explain this observation. First, in these
experiments we employed RNAi and even though the
knockdown was potent (>90% and 84% on mRNA level
for LEDGF/p75 and HRP-2 respectively), residual
LEDGF/p75 and HRP-2 might account for the residual
bias. The generation of a human double KO cell line, de-
void of both LEDGF/p75 and HRP-2, will provide a
more definite answer. Second, this result could suggest
the presence of additional cellular co-factor(s) that affect
targeting in the absence of LEDGF/p75 and HRP-2.
Transcription factor IIS (TFIIS) for example harbors an
IBD-like domain [6,8], although structurally moredistantly related to the IBD of LEDGF/p75 and HRP-2,
but lacks a PWWP-domain. However, in the presence of
LEDGF/p75, HRP-2 does not seem to play a role in HIV
replication [6] or targeting (this work), suggesting alter-
nate IBD containing tethers will probably only play a
minor role in HIV replication or targeting in WT condi-
tions, unless expression levels differ strongly, accrediting
LEDGF/p75 as principal tether [6]. Third, the bias might
reflect specific constraints of the viral IN, the local chro-
matin environment or the pre-integration complex itself.
Although HIV integration favors weak palindromic
sequences, our analysis indicated that this preference is
irrespective of the presence or absence of LEDGF/p75
and/or HRP-2 ([6] and data not shown).
In conclusion, our data provide an explanation for
why LEDGF/p75 depletion alone does not completely
retarget integration distribution towards random, and
they fit with previous data that HRP-2 binds the IN
dimer with lower affinity [7,9]. These data also reinforce
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cellular co-factor determining HIV-1 integration site
selection.
Additional files
Additional file 1: HRP-2 overexpression relocates integrase to the
nucleus of LEDGF/p75 depleted cells. Cells were transfected with
plasmid encoding mRFP-IN and laser scanning microscopy images of
cells stained with anti-LEDGF/p75 (LEDGF/p75) or anti-Flag (HRP-2)
antibody are shown (green). Nuclei were stained with DAPI (4’,6-
diamidino-2-phenylindole; blue). The respective constructs and cell lines
are indicated. Interphase and mitotic cells are displayed separately. The
data are representative for the vast majority of the imaged cells.
Additional file 2: Heat map of integration frequency relative to
genomic features. Heat maps were developed to summarize
relationships of proviral integration sites with genomic features using the
receiver operating characteristic (ROC) area method [20]. The analyzed
genomic features are mentioned on the left of the corresponding row of
the heat map. Tile color indicates whether a chosen feature is favored
(red, enrichment compared with random) or disfavored (blue, depletion
compared with random) for integration for the respective data sets
relative to their MRCs, as detailed in the colored ROC area scale at the
bottom of the panel. The different data sets used are indicated above the
columns. The asterisks denote significant differences of HIV integration
compared to the LEDGF/p75 KD cell line for the respective features
(*, p< 0.05, **, p < 0.01; ***, p< 0.001, using Wald statistics referred to a
Chi-square distribution), dashes overlay control tiles. The naming of the
genomic features is described in Berry et al. [20]; TSS, transcription
start site.
Additional file 3: Table S1. Integration frequency of HIV-derived
lentiviral vector in RefSeq genes.
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